How Micrornas Affect the Expression of Human Leukocyte Antigeng in Pregnancy
Ayla Carmel Kempers1, Marie Van Dijk1 & Cees Oudejans1 Show affiliations
- VU University Medical Center, The Netherlands
American Journal of Immunology, Volume 8, Issue 4, pp. 136–145 · doi.org/10.3844/ajisp.2012.136.145
Abstract
The expression of Human Leukocyte Antigen G (HLA-G) on Fetal Extravillous Trophoblast (EVT) cells during pregnancy plays an important role in preventing the fetus from rejection by suppressing the maternal immune system. Decreased expression levels of HLA-G have already shown to be associated with several complications of pregnancy such as pre-eclampsia. However, it remains largely unknown how HLA-G gene expression is regulated with regard to its function and its complications. Polymorphisms and microRNAs affect HLA-G gene expression and the formation of isoforms. Interestingly, three microRNAs, miR-148a, miR-148b and miR-152, downregulate HLA-G expression with functional consequences. Since HLA-G expression levels are reduced in pre-eclampsia without a known cause, we hypothesize that these microRNAs are involved in the development of pre-eclampsia. This review discusses how microRNAs can affect HLA-G gene expression and its functions. Additionally, the role of microRNAs in the development of pre-eclampsia will be reviewed.
Licence and reuse
Free to read. This article carries the publisher’s copyright, as printed on it: © 2012 Science Publications. It is free to read; ask us before reusing it.
How to reuse this articleResponses (0)
About this article
Kempers, A. C., Dijk, M. V. & Oudejans, C. (2012). How Micrornas Affect the Expression of Human Leukocyte Antigeng in Pregnancy. American Journal of Immunology, 8(4), 136–145. https://doi.org/10.3844/ajisp.2012.136.145
- Licence
- © Science Publications
- Issue
- Volume 8, Issue 4
- Policies
- Editorial independenceUse of generative AIData availabilityAppeals and complaints
- Version
- Version of record
